Chemoprevention by inducers of carcinogen detoxication enzymes

Environmental Health Perspectives

Volumn 105, Issue SUPPL. 4, 1997, Pages 965-970

  Kensler, Thomas W ^a,b  

^a Johns Hopkins University   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

1,2 Dithiole 3 thione; Aflatoxin B1; Biomarkers; Enzyme induction; Glutathione S transferases; NAD(P)H:quinone reductase; Oltipraz

Indexed keywords

1,2 DITHIOLE 3 THIONE DERIVATIVE; AFLATOXIN; GLUCURONOSYLTRANSFERASE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; MESSENGER RNA; OLTIPRAZ; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER PREVENTION; CARCINOGENESIS; CHEMOPROPHYLAXIS; CHINA; CONFERENCE PAPER; CONJUGATE; DNA ADDUCT; DNA FLANKING REGION; DRUG HALF LIFE; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME SUBUNIT; GENETIC TRANSCRIPTION; HIGH RISK POPULATION; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; RAT; URINE LEVEL;

ANIMALIA; RODENTIA;

EID: 0030868098     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.97105s4965     Document Type: Conference Paper

References (55)

1. Wattenberg LW. Chemoprevention of cancer. Cancer Res 45:1-8 (1985).
2. De Flora S, Ramel C. Mechanisms of inhibitors of mutagenesis and carcinogenesis. Classification and overview. Mutat Res 202:285-306 (1988).
3. Miller EC, Miller JA. Some historical perspectives on the metabolism of xenobiotic chemicals to reactive electrophiles. In: Bioactivation of Foreign Compounds (Anders MW, ed). New York:Academic Press, 1985; 1-28.
4. Conney AH. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: GHA Clowes Memorial Lecture. Cancer Res 42:4875-4917 (1982).
5. Benson AM, Batzinger RP, Ou S-YL, Bueding E, Cha Y-N, Talalay P. Elevation of hepatic glutathione S-transferase activities and protection against mutagenic metabolites of benzo[a]pyrene by dietary antioxidants. Cancer Res 38:4486-4495 (1978).
6. Benson AM, Cha Y-N, Bueding E, Heine HS, Talalay P. Elevation of extrahepatic glutathione 5-transferases and epoxide hydratase activities by 2(3)-tert-butyl-4-hydroxyanisole. Cancer Res 39:2971-2977 (1979).
7. Lam LKT, Sparnins VL, Wattenberg LW. Isolation and identification of kahweol palmitate and cafestrol palmitate as active constituents of green coffee beans that enhance glutathione S-transferase activity in the mouse. Cancer Res 42:1193-1198 (1982).
8. Zhang Y, Talalay P, Cho C-G, Posner GH. A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci USA 89:2399-2403 (1992).
9. Zhang Y, Kensler TW, Cho C-G, Posner GH, Talalay P. Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc Natl Acad Sci USA 91:3147-3150 (1994).
10. Bueding E, Dolan P, Leroy JP. The antischistosomal activity of oltipraz. Res Commun Chem Pathol Pharmacol 37:293-303 (1982).
11. Kensler TW, Helzlsouer KJ. Oltipraz: clinical opportunities for cancer chemoprevention. J Cell Biochem 22S:101-107 (1995).
12. Kelloff GJ, Crowell JA, Boone CW, Steele VE, Lubet RA, Greenwald P, Alberts DS, Covey JM, Doody LA, Knapp GG et al. Clinical development plan: oltipraz. J Cell Biochem 20S:205-218 (1994).
13. Pearson WR, Windle JJ, Morrow JF, Benson AM, Talalay P. Increased synthesis of glutathione S-transferase in response to anticarcinogenic antioxidants. Cloning and measurement of messenger RNA. J Biol Chem 258:2052-2062 (1983).
14. Benson AM, Hunkeler MJ, Morrow JF. Kinetics of glutathione transferase messenger RNA, and reduced nicotinamide adenine dinucleotide (phosphate):quinone reductase induction by 2(3)-tert-butyl-4-hydroxyanisole in mice. Cancer Res 44:5256-5261 (1984).
15. Pearson WR, Reinhart J, Sisk RC, Anderson KS, Adler PN. Tissue-specific induction of murine glutathione transferase mRNAs by butylated hydroxyanisole. J Biol Chem 263:13324-13332 (1988).
16. Prochaska HJ, Talalay P. Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver. Cancer Res 48:4776-4782 (1988).
17. Fisher JM, Wu L, Denison MS, Whitlock JP Jr. Organization and function of a dioxin-responsive enhancer. J Biol Chem 265:9676-9681 (1990).
18. Prochaska HJ, Bregman HS, DeLong MJ, Talalay P. Specificity of induction of cancer protective enzymes by analogues of tert-butyl-4-hydroxyanisole (BHA). Biochem Pharmacol 34:3909-3914 (1985).
19. Prochaska HJ, DeLong MJ, Talalay P. On the mechanisms of induction of cancer-protective enzymes: a unifying proposal. Proc Natl Acad Sci USA 82:8232-8236 (1985).
20. Talalay P, DeLong MJ, Prochaska HJ. Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis. Proc Natl Acad Sci USA 85:8261-8265 (1988).
21. Prestera T, Holtzclaw WD, Zhang Y, Talalay P. Chemical and molecular regulation of enzymes that detoxify carcinogens. Proc Natl Acad Sci USA 90:2965-2969 (1993).
22. Friling RS, Bensimon A, Tichauer Y, Daniel V. Xenobiotic-inducible expression of murine glutathione S-transferase Ya sub-unit gene is controlled by an electrophile-responsive element. Proc Natl Acad Sci USA 87:6258-6262 (1990).
23. Rushmore TH, King RG, Paulson KE, Pickett CB. Regulation of glutathione 5-transferase Ya subunit gene expression: identification of a unique xenobiotic-responsive element controlling inducible expression by planar aromatic compounds. Proc Natl Acad Sci USA 87:3826-3830 (1990).
24. Jaiswal AK. Antioxidant response element. Biochem Pharmacol 48:439-444 (1994).
25. Park BK, Kitteringham NR. Assessment of enzyme induction and enzyme inhibition in humans: toxicological implications. Xenobiotica 20:1171-1185 (1990).
26. Pantuck EJ, Pantuck CB, Garland WA, Min BH, Wattenberg LW, Anderson KE, Kappas A, Conney AH. Stimulatory effect of brussels sprouts and cabbage on human drug metabolism. Clin Pharmacol Ther 25:88-95 (1979).
27. Miners JO, Attwood J, Birkett DJ. Determinants of acetaminophen metabolism: effect of inducers and inhibitors of drug metabolism on acetaminophen's metabolic pathways. Clin Pharmacol Ther 35:480-486 (1984).
28. Chasseaud LF. Determination of thioethers as biochemical markers for monitoring exposure to potential toxicants. In: Glutathione Conjugation (Anders MW, ed). New York:Academic Press, 1988;391-413.
29. Bogaards JJP, Verhagen H, Willems MI, van Poppel G, van Bladeren PJ. Consumption of brussels sprouts results in elevated α-class glutathione S-transferase levels in human blood plasma. Carcinogenesis 15:1073-1075 (1994).
30. Prochaska HJ, Fernandes CL. Elevation of serum phase II enzymes by anticarcinogenic enzyme inducers: markers for a chemoprotected state? Carcinogenesis 14:2441-2445 (1993).
31. Gordon GB, Prochaska HJ, Yang LY-S. Induction of NAD(P)H:quinone reductase in human peripheral blood lymphocytes. Carcinogenesis 12:2393-2396 (1991).
32. Gupta E, Olopade OL, Ratain MJ, Mick R, Baker TM, Berezin FK, Benson AB III, Dolan ME. Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agent. Clin Cancer Res 1:1133-1138 (1995).
33. Sreerama L, Hedge MW, Sladek NE. Identification of a class 3 aldehyde dehydrogenase in human saliva and increased levels of this enzyme, glutathione S-transferases, and DT-diaphorase in the saliva of subjects who continually ingest large quantities of coffee or broccoli. Clin Cancer Res 1:1153-1163 (1995).
34. Benson AB III. Oltipraz: a laboratory and clinical review. J Cell Biochem 17F:278-291 (1993).
35. Busby WF Jr, Wogan GN. Aflatoxins. In: Chemical Carcinogens. 2nd ed (Searle CE, ed). Washington:American Chemical Society, 1984;945-1136.
36. 1 in rats. Cancer Lett 19:125-132 (1983).
37. 1 induced hepatocarcinogenesis by the phenolic antioxidants, burylated hydroxytoluene and butylated hydroxyanisole. Carcinogenesis 7:1043-1050 (1986).
38. 1-induced hepatocarcinogenesis in rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-hione (oltipraz): predictive role for short-term molecular dosimetry. Cancer Res 51:5501-5506 (1991).
39. Zhu Y-R, Chen J-G, Huang X-Y. Hepatocellular carcinoma in Qidong County. In: Primary Liver Cancer (Tang Z-Y, Wu N-C, Xia S-S, eds). Beijing:China Academic Publishers, 1988;204-222.
40. 1-induced preneoplastic foci in a rat model of hepatic tumorigenesis. Carcinogenesis 14:2423-2425 (1993).
41. Kensler TW, Egner PA, Dolan PM, Groopman JD, Roebuck BD. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. Cancer Res 47:4271-4277 (1987).
42. Primiano T, Egner PA, Sutter TR, Kelloff GJ, Roebuck BD, Kensler TW. Intermittent dosing with oltipraz: relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases. Cancer Res 55:4319-4324 (1995).
43. 1 exo-and endo-poxides by rat and human glutathione S-transferases. Chem Res Toxicol 5:470-478 (1992).
44. Davidson NE, Egner PA, Kensler TW. Transcriptional control of glutathione S-transferase gene expression by the chemoprotective agent 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz) in rat liver. Cancer Res 50:2251-2255 (1990).
45. Egner PA, Kensler TW, Prestera T, Talalay P, Libby AH, Joyner HH, Curphey TJ. Regulation of phase 2 enzyme induction by oltipraz and other dithiolethiones. Carcinogenesis 15:177-181 (1994).
46. Morel F, Fardel O, Meyer DJ, Langouet S, Gilmore KS, Meunier B, Tu C-PD, Kensler TW, Ketterer B, Guillouzo A. Preferential increase of glutathione S-transferase class alpha transcripts in cultured human hepatocytes by phenobarbital, 3-methylcholanthrene and dithiolethiones. Cancer Res 53:231-234 (1993).
47. Buetler TM, Gallagher EP, Wang C, Stahl DL, Hayes JD, Eaton DL. Induction of phase I and phase II drug-metabolizing enzyme mRNA, protein, and activity by BHA, etnoxyquin, and oltipraz. Toxicol Appl Pharmacol 135:45-57 (1995).
48. 1 metabolism. Fed Am Soc Exp Biol J 5:A1517 (1991).
49. 1 metabolism in human hepatocytes in primary culture. Cancer Res 55:5574-5579 (1995).
50. 1 excretion in rat urine during dietary intervention with oltipraz. Carcinogenesis 17:1385-1388 (1996).
51. Wang J-S, Qian G-S, Zarba A, He Z, Zhu Y-R, Zhang B-C, Jacobson L, Gange SJ, Munoz A, Kensler TW et al. Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen positive and negative residents of Daxin, Qidong County, People's Republic of China. Cancer Epidemiol Biomarkers Prev 5:253-262 (1996).
52. Qian G-S, Ross RK, Wu MC, Yuan J-M, Gan Y-T, Henderson BE, Wogan GN, Groopman JD. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev 3:3-10 (1994)
53. Groopman JD, Zhu J, Donahue PR, Pikul A, Zhang L-S, Chen J-S, Wogan GN. Molecular dosimetry of urinary aflatoxin DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China. Cancer Res 52:45-51 (1992).
54. Egner PA, Gange SJ, Dolan PM, Groopman JD, Muñoz A, Kensler TW. Levels of aflatoxin-albumin biomarkers in rat plasma are modulated by both long-term and transient interventions with oltipraz. Carcinogenesis 16:1769-1773 (1995).
55. Jacobson LP, Zhang B-C, Zhu Y-R, Wang J-B, Wu Y, Zhang Q-N, Yu Y-L, Qian G-S, Kuang S-Y, Li Y-F et al. Oltipraz chemoprevention trial in Qidong, People's Republic of China: study design and clinical outcomes. Cancer Epidemiol Biomarkers Prev 6:257-265 (1997).